Conference Coverage

Surgery Improves Cure Rate in Advanced MDR-TB

Published in TB and Outbreaks Week, June 12th, 1995

Surgery was largely responsible for a dramatic increase in the cure rate among patients with multidrug resistant tuberculosis (MDR-TB) treated at Denver's National Jewish Center for Immunology and Respiratory Medicine during the past decade.

The cure rate of MDR-TB patients increased from 56 percent between 1973 and 1983 to 85 percent between 1983-1993, National Jewish Center (NJC) researcher Michael Iseman revealed at the 1995 American Thoracic Society/American Lung Association International Conference, held May 20-24, 1995, in Seattle, Washington.

From 1983 to 1993, 140 patients with drug-resistant pulmonary TB were treated at NJC. Of these...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1995-06-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry